Cargando…
Production of glycoprotein vaccines in Escherichia coli
BACKGROUND: Conjugate vaccines in which polysaccharide antigens are covalently linked to carrier proteins belong to the most effective and safest vaccines against bacterial pathogens. State-of-the art production of conjugate vaccines using chemical methods is a laborious, multi-step process. In vivo...
Autores principales: | Ihssen, Julian, Kowarik, Michael, Dilettoso, Sandro, Tanner, Cyril, Wacker, Michael, Thöny-Meyer, Linda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927510/ https://www.ncbi.nlm.nih.gov/pubmed/20701771 http://dx.doi.org/10.1186/1475-2859-9-61 |
Ejemplares similares
-
Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB
por: Ihssen, Julian, et al.
Publicado: (2012) -
Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering
por: Ihssen, Julian, et al.
Publicado: (2015) -
In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation
por: Kämpf, Michael M, et al.
Publicado: (2015) -
Biochemical properties and yields of diverse bacterial laccase-like multicopper oxidases expressed in Escherichia coli
por: Ihssen, Julian, et al.
Publicado: (2015) -
High level production of tyrosinase in recombinant Escherichia coli
por: Ren, Qun, et al.
Publicado: (2013)